Sanjay Chaudhary
56 posts

Sanjay Chaudhary
@sanjayCCM
Critical care physician and ECLS enthusiast at Mayo Clinic Jacksonville. Tweets are my own.
Jacksonville, FL Katılım Nisan 2009
281 Takip Edilen235 Takipçiler
Sanjay Chaudhary retweetledi

Livestream from #ELSO2024 ongoing! 🧵3/x
🍾Tribute to Dr Robert H. Bartlett
Founder & Emeritus Board of Directors @ELSOOrg Founder and Director #ECLS Lab at @umichmedicine
🎥 youtube.com/watch?v=GuVFLJ…

YouTube




English
Sanjay Chaudhary retweetledi

🌟 Join Us at the Forefront of Critical Care Medicine!
🔍 Discover the future at the Innovative Horizons: Transforming Critical Care Medicine 2024 symposium, hosted by the prestigious @MayoClinic
📅 August 9-11, 2024 📍 Jacksonville, FL 🌐
English
Sanjay Chaudhary retweetledi
Sanjay Chaudhary retweetledi

ECMO by definition is “temporary” life support - how do you define temporary? Many implications for pharmacotherapy on ECMO! Had a great time speaking at #MayoECMO2023
@MayoAnesthesia @MayoAnesRes @MayoClinicCCM @MFAFlorida
Pramod K Guru.MBBS,MD,DM,FASN@pkguru10
Embracing the Objectives… More importantly the Values & Virtues!!! ➡️ Pharmacotherapy on #ECMO Thanks @pwierusz for enlightening us. #MayoECMO2023 #MayoECMO #ECMO #Extracorporeal #Support #MayoClinicFL
English
Sanjay Chaudhary retweetledi

Thrilled To Welcome The Critical Care Fellow To #MayoClinicFL 💐
💐💐💐Congratulations 💐💐💐
#Welcome To #CriticalCareFamily 🙌
#Fellowshipmatch2023 #FellowMatch #MayoClinicFL
@pkguru10 @sanjayCCM @pmorenofranco @Dev_Sanghavi @anirbanb_007 @nathanhwaldron

English

It was great to collaborate with Kianoush Kashani on this review for Interventional cardiology clinics.
Mayo Clinic Nephrology@MayoClinicNeph
AKI management strategies peri-cardiovascular interventions - risk stratification, hemodynamic optimization and multidisciplinary collaborative care remain essential to this pervasive undesirable complication. @kianoushbk @sanjayCCM #MayoClinicKidney sciencedirect.com/science/articl…
English

@anupamuab Congratulations Dr Agarwal! It’s a matter of immense happiness and pride for PGI alumni across the world.
English

Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study - The Lancet Respiratory Medicine thelancet.com/journals/lanre…
English
Sanjay Chaudhary retweetledi

Great insights on transfusion threshold during VV ECMO.
🩸PRBC transfusion - invariably associated with lower mortality only when Hb< 7 g/dL
Was a great prospective study to be a part of.
#section-7c530872-6235-4433-899c-b3f276970189" target="_blank" rel="nofollow noopener">thelancet.com/journals/lanre…
@GraemeMacLaren @ELSOOrg @FOAMecmo @LancetRespirMed

English

@nathanhwaldron @pkguru10 @pmorenofranco @paragpatelmd Will acetazolamide unite or divide? Oh wait, it’ll be on back order.
English
Sanjay Chaudhary retweetledi

#ADVOR trial: acetazolamide added to intravenous loop diuretics decreases congestion within 3 days in patients with acute decompensated #heartfailure.
#ESCCongress

English
Sanjay Chaudhary retweetledi
Sanjay Chaudhary retweetledi

The annual #mayoclinic #Florida #ValueSymposium serves as a celebration among colleagues to share stories and examples of #processimprovements that positively influence #outcomes in patient #safety, #service, #experience, and #equ…lnkd.in/e7njeHTE lnkd.in/euSaVMMD
English
Sanjay Chaudhary retweetledi

New @TheLancet
The first prospective study of #LongCovid with symptoms documented before Covid and w/age and sex-matched controls
1 in 8 people (12.7%) developed Long Covid after #SARSCoV2 infections
thelancet.com/journals/lance…

English
Sanjay Chaudhary retweetledi

Wow. A wearable ultrasound patch for continuous, on the go, high-quality imaging of most parts the human body.
A remarkable new innovation with diverse clinical applications @ScienceMagazine science.org/doi/10.1126/sc… @ProfZhaoMIT @ChongheWang @MIT @MITMechE




English
Sanjay Chaudhary retweetledi

Extracorporeal hemoadsorption + VV #ECMO, large nationwide 🇩🇪 cohort
🧽 > 7.6K pts; among these use of hemoadsorption as treatment adjunct constantly increased from 6.6% in 2017 to 11.8% in 2019
🧽 no additional benefit, ⬆️ mortality/costs
@asaiojournal
📎 bit.ly/3ySjjlu

English






